{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:59:44Z","timestamp":1790164784681,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13877-4","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:27:32Z","timestamp":1782926852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of conventional antimicrobial agents against carbapenem resistant non-carbapenem \u03b2-lactams susceptible Pseudomonas aeruginosa infection in critically ill patients: a multicentre retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Sheng-Huei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Yao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Chyun","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biing-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yih","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hsuan","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi\u2011Lin","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Kan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"T-CARE (Taiwan Critical Care and Infection) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"15","key":"13877_CR1","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA. 2020;323(15):1478\u201387.","journal-title":"JAMA"},{"issue":"6","key":"13877_CR2","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.chest.2020.06.034","volume":"158","author":"SP Bergin","year":"2020","unstructured":"Bergin SP, Coles A, Calvert SB, Farley J, Powers JH, Zervos MJ, et al. PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the ICU. Chest. 2020;158(6):2370\u201380.","journal-title":"Chest"},{"key":"13877_CR3","doi-asserted-by":"publisher","first-page":"1137811","DOI":"10.3389\/fmicb.2023.1137811","volume":"14","author":"Q Yuan","year":"2023","unstructured":"Yuan Q, Guo L, Li B, Zhang S, Feng H, Zhang Y, et al. Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study. Front Microbiol. 2023;14:1137811.","journal-title":"Front Microbiol"},{"issue":"1","key":"13877_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s43856-024-00696-4","volume":"4","author":"JK Valik","year":"2024","unstructured":"Valik JK, Giske CG, Hasan B, Gozalo-Marg\u00fcello M, Mart\u00ednez-Mart\u00ednez L, Premru MM, et al. Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infection. Commun Med (Lond). 2024;4(1):264.","journal-title":"Commun Med (Lond)"},{"issue":"4","key":"13877_CR5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s15010-024-02453-0","volume":"53","author":"J Kessel","year":"2025","unstructured":"Kessel J, Bug G, Steffen B, Brunnberg U, Vehreschild M, Weber S, et al. Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort study. Infection. 2025;53(4):1383\u201392.","journal-title":"Infection"},{"key":"13877_CR6","doi-asserted-by":"crossref","unstructured":"Jesudason T. WHO publishes updated list of bacterial priority pathogens. Lancet Microbe. 2024;5(9).","DOI":"10.1016\/j.lanmic.2024.07.003"},{"issue":"1","key":"13877_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177\u201392.","journal-title":"Biotechnol Adv"},{"key":"13877_CR8","doi-asserted-by":"crossref","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. 2024.","DOI":"10.1093\/cid\/ciae403"},{"issue":"1","key":"13877_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bjid.2016.10.008","volume":"21","author":"EH Campana","year":"2017","unstructured":"Campana EH, Xavier DE, Petrolini FV, Cordeiro-Moura JR, Araujo MR, Gales AC. Carbapenem-resistant and cephalosporin-susceptible: a worrisome phenotype among Pseudomonas aeruginosa clinical isolates in Brazil. Braz J Infect Dis. 2017;21(1):57\u201362.","journal-title":"Braz J Infect Dis"},{"issue":"11","key":"13877_CR10","doi-asserted-by":"publisher","first-page":"e0120421","DOI":"10.1128\/AAC.01204-21","volume":"65","author":"CM Gill","year":"2021","unstructured":"Gill CM, Akta\u015f E, Alfouzan W, Bourassa L, Brink A, Burnham CD, et al. Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization. Antimicrob Agents Chemother. 2021;65(11):e0120421.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"13877_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.diagmicrobio.2013.11.014","volume":"78","author":"ZR Zeng","year":"2014","unstructured":"Zeng ZR, Wang WP, Huang M, Shi LN, Wang Y, Shao HF. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China. Diagn Microbiol Infect Dis. 2014;78(3):268\u201370.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"13877_CR12","doi-asserted-by":"crossref","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. Eur Respir J. 2017;50(3).","DOI":"10.1183\/13993003.00582-2017"},{"key":"13877_CR13","doi-asserted-by":"publisher","first-page":"107128","DOI":"10.1016\/j.ijid.2024.107128","volume":"146","author":"SH Wang","year":"2024","unstructured":"Wang SH, Teng CK, Chan MC, Yang KY, Sheu CC, Liang SJ, et al. The impact and risk factors for developing pneumogenic bacteremia in carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia in the intensive care unit: A multicenter retrospective study. Int J Infect Dis. 2024;146:107128.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"13877_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00134-020-05950-6","volume":"46","author":"JF Timsit","year":"2020","unstructured":"Timsit JF, Rupp\u00e9 E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46(2):266\u201384.","journal-title":"Intensive Care Med"},{"key":"13877_CR15","doi-asserted-by":"crossref","unstructured":"Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol. 2020;58(3).","DOI":"10.1128\/JCM.01864-19"},{"key":"13877_CR16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2147\/IDR.S174876","volume":"11","author":"S Li","year":"2018","unstructured":"Li S, Jia X, Li C, Zou H, Liu H, Guo Y, et al. Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia. Infect Drug Resist. 2018;11:1225\u201335.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"13877_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1556\/030.66.2019.036","volume":"66","author":"Y Khalili","year":"2019","unstructured":"Khalili Y, Yekani M, Goli HR, Memar MY. Characterization of carbapenem-resistant but cephalosporin-susceptible Pseudomonas aeruginosa. Acta Microbiol Immunol Hung. 2019;66(4):529\u201340.","journal-title":"Acta Microbiol Immunol Hung"},{"key":"13877_CR18","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs M. Carbapenem-resistant but cephalosporin-susceptible pseudomonas aeruginosa in urinary tract infections: opportunity for colistin sparing. Antibiot (Basel). 2020;9(4).","DOI":"10.3390\/antibiotics9040153"},{"issue":"10","key":"13877_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.cmi.2021.01.020","volume":"27","author":"JY Feng","year":"2021","unstructured":"Feng JY, Peng CK, Sheu CC, Lin YC, Chan MC, Wang SH, et al. Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study. Clin Microbiol Infect. 2021;27(10):1465\u201373.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"13877_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-022-03947-9","volume":"26","author":"SH Wang","year":"2022","unstructured":"Wang SH, Yang KY, Sheu CC, Chen WC, Chan MC, Feng JY, et al. The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study. Crit Care. 2022;26(1):91.","journal-title":"Crit Care"},{"issue":"1","key":"13877_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13613-025-01580-7","volume":"15","author":"CL Chen","year":"2025","unstructured":"Chen CL, Yang KY, Peng CK, Chan MC, Sheu CC, Feng JY, et al. Outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections in intensive care units and prognostic effect of different antimicrobial regimens. Ann Intensive Care. 2025;15(1):162.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"13877_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/1348-0421.12021","volume":"57","author":"P Khuntayaporn","year":"2013","unstructured":"Khuntayaporn P, Montakantikul P, Santanirand P, Kiratisin P, Chomnawang MT. Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand. Microbiol Immunol. 2013;57(3):170\u20138.","journal-title":"Microbiol Immunol"},{"key":"13877_CR23","doi-asserted-by":"crossref","unstructured":"Wi YM, Choi JY, Lee JY, Kang CI, Chung DR, Peck KR, et al. Antimicrobial Effects of \u03b2-lactams on imipenem-resistant ceftazidime-susceptible pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017;61(6).","DOI":"10.1128\/AAC.00054-17"},{"key":"13877_CR24","doi-asserted-by":"crossref","unstructured":"Zaidenstein R, Miller A, Tal-Jasper R, Ofer-Friedman H, Sklarz M, Katz DE, et al. Therapeutic management of pseudomonas aeruginosa bloodstream infection non-susceptible to carbapenems but susceptible to old cephalosporins and\/or to penicillins. Microorganisms. 2018;6(1).","DOI":"10.3390\/microorganisms6010009"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13877-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13877-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13877-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:02:11Z","timestamp":1790161331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13877-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13877"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13877-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was in accordance with the principles of the Declaration of Helsinki. This study was approved by the Institutional Review Boards (IRBs) of five hospitals, and informed consent was waived due to the retrospective study design. The IRB registration numbers were A202005146 (Tri-Service General Hospital), CMUH110-REC1-139 (China Medical University Hospital), CE18100A (Taichung Veterans General Hospital), 2020-11-006AC (Taipei Veterans General Hospital), and KMUHIRB-E(I)-20180141 (Kaohsiung Medical University Hospital).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1698"}}